You just read:

Neurocrine Biosciences Presents Long-term Data Analyses from Open-label KINECT 4 Phase III Study Demonstrating INGREZZA® Improves Tardive Dyskinesia Symptoms

News provided by

Neurocrine Biosciences, Inc.

Dec 04, 2017, 15:01 EST